Samuel Hellman to Female
This is a "connection" page, showing publications Samuel Hellman has written about Female.
Connection Strength
0.188
-
Letrozole in breast cancer. N Engl J Med. 2004 Feb 12; 350(7):727-30; author reply 727-30.
Score: 0.012
-
Sun Valley summary. Consensus and action items Expedition Inspiration meeting 2000. Breast Cancer Res Treat. 2001 Apr; 66(3):179-82.
Score: 0.010
-
Individual characterisation of the metastatic capacity of human breast carcinoma. Eur J Cancer. 2000 Aug; 36(13 Spec No):1631-9.
Score: 0.009
-
The clinical significance of tumor progression: breast cancer as a model. Cancer J. 2000 Apr; 6 Suppl 2:S131-3.
Score: 0.009
-
Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol. 2000 Feb; 18(3):591-9.
Score: 0.009
-
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res. 2000 Jan 15; 60(2):298-304.
Score: 0.009
-
Aging, progression, and phenotype in breast cancer. J Clin Oncol. 1998 Aug; 16(8):2686-92.
Score: 0.008
-
The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer. Cancer Res. 1998 Jul 01; 58(13):2766-71.
Score: 0.008
-
The benefits of mammography are not limited to women of ages older than 50 years. Cancer. 1998 Jun 01; 82(11):2221-6.
Score: 0.008
-
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793.
Score: 0.008
-
Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res Treat. 1998; 52(1-3):147-58.
Score: 0.008
-
Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J Sci Am. 1997 Jul-Aug; 3(4):224-9.
Score: 0.007
-
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol. 1997 Jun; 15(6):2329-37.
Score: 0.007
-
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst. 1996 Dec 04; 88(23):1764-9.
Score: 0.007
-
Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. J Clin Oncol. 1996 Dec; 14(12):3105-11.
Score: 0.007
-
The patient and the public good. Monash Bioeth Rev. 1996 Jan; 15(1):S5-10.
Score: 0.007
-
The patient and the public good. Nat Med. 1995 May; 1(5):400-2.
Score: 0.006
-
Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol. 1995 May; 13(5):1144-51.
Score: 0.006
-
Dogma and inquisition in medicine. Breast cancer as a case study. Cancer. 1993 Apr 01; 71(7):2430-3.
Score: 0.006
-
MicroRNA expression characterizes oligometastasis(es). PLoS One. 2011; 6(12):e28650.
Score: 0.005
-
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2012 Jun 01; 118(11):2962-70.
Score: 0.005
-
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res. 2008 Aug 15; 14(16):5255-9.
Score: 0.004
-
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004 Dec; 25(6):1677-83.
Score: 0.003
-
The natural history of breast carcinoma in the elderly: implications for screening and treatment. Cancer. 2004 May 01; 100(9):1807-13.
Score: 0.003
-
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003. Breast Cancer Res Treat. 2003 Jul; 80(2):139-44.
Score: 0.003
-
Consensus statement: Expedition Inspiration fund for breast cancer research meeting 2002. Breast Cancer Res Treat. 2003 Mar; 78(1):127-31.
Score: 0.003
-
Transcriptional control of viral gene therapy by cisplatin. J Clin Invest. 2002 Aug; 110(3):403-10.
Score: 0.003
-
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res. 2000 Dec 15; 60(24):6958-63.
Score: 0.002
-
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res. 1998 Dec 15; 58(24):5686-9.
Score: 0.002
-
Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature. Cancer Res. 1996 Oct 01; 56(19):4311-4.
Score: 0.002
-
Genetic radiotherapy overcomes tumor resistance to cytotoxic agents. Cancer Res. 1995 Dec 01; 55(23):5561-5.
Score: 0.002